We are live on ! Find out more
STLN

Starling Oncology Institute, Inc. Common Stock
STLN

38 hedge funds and large institutions have $80.8M invested in Starling Oncology Institute, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

81% more funds holding

Funds holding: 21 → 38 (+17)

64% more capital invested

Capital invested by funds: $49.3M → $80.8M (+$31.5M)

18.78% more ownership

Funds ownership: 21.97% → 40.75% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
38
Holders Change
+17
Holders Change %
+80.95%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
2
Reduced
2
Closed
3
Calls
$738K
Puts
–
Net Calls
+$738K
Net Calls Change
-$401K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$15.2M
2
JP Morgan Chase
JP Morgan Chase
New York
+$6.23M
3
GCL
Glazer Capital LLC
New York
+$4.42M
4
KC
Kepos Capital
New York
+$4.35M
5
WAM
Wolverine Asset Management
Illinois
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$4.83M
2
OCAM
Owl Creek Asset Management
New York
-$2.01M
3
BCM
Basso Capital Management
Connecticut
-$1.46M
4
MIM
Monashee Investment Management
Massachusetts
-$754K
5
JG
Jefferies Group
New York
-$526K
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
26
Alpine Global Management
New York
$664K +$666K +64,081 New
CC
27
Centiva Capital
New York
$518K – – –
DCM
28
Dupont Capital Management
Delaware
$518K – – –
MAM
29
Myriad Asset Management
Hong Kong
$509K +$509K +49,000 New
MSU
30
Mizuho Securities USA
New York
$508K +$519K +50,000 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$491K +$519K +50,000 New
AFS
32
Amtrust Financial Services
New York
$260K +$260K +25,000 New
AA
33
AQR Arbitrage
Connecticut
$259K – – –
PAM
34
Panagora Asset Management
Massachusetts
$52K +$52.5K +5,052 New
Millennium Management
35
Millennium Management
New York
$16.4K +$15.2M +1,466,800 +1,336%
UBS Group
36
UBS Group
Switzerland
$16K +$16.1K +1,546 New
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$3K – – –
Morgan Stanley
38
Morgan Stanley
New York
$1K +$779 +75 New
OCAM
39
Owl Creek Asset Management
New York
– -$2.01M -199,996 Closed
BCM
40
Basso Capital Management
Connecticut
– -$1.46M -145,485 Closed
MIM
41
Monashee Investment Management
Massachusetts
– -$754K -74,996 Closed
1
2

STLN Hedge Fund Activity: Q3 2020 in Review

38 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Institute, Inc. Common Stock (STLN) for Q3 2020, worth a combined $80.8M — up 64% from $49.3M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new STLN positions and 3 closed out — a net gain of 17 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Millennium Management, adding an estimated $15.2M. The largest seller was UBS O'Connor, cutting an estimated $4.83M.

  • 38 institutional investors held Starling Oncology Institute, Inc. Common Stock (STLN) as of Q3 2020, up from 21 in Q2 2020.
  • Funds reported $80.8M of Starling Oncology Institute, Inc. Common Stock stock for Q3 2020, up 64% quarter-over-quarter.
  • 20 funds opened new Starling Oncology Institute, Inc. Common Stock positions in Q3 2020 and 3 closed out, a net change of +17 holders.
  • The largest Starling Oncology Institute, Inc. Common Stock buyer in Q3 2020 was Millennium Management, an estimated $15.2M added.
  • The largest Starling Oncology Institute, Inc. Common Stock seller in Q3 2020 was UBS O'Connor, an estimated $4.83M sold.

Based on aggregated 13F filings for Q3 2020.